Insufficient scRNA-seq data for expression of KLK14 at single-cell level.
Insufficient scRNA-seq data for expression of KLK14 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 68.78 | 179 / 180 | 90% | 20.36 | 389 / 430 |
prostate | 97% | 56.85 | 237 / 245 | 70% | 20.00 | 349 / 502 |
brain | 93% | 59.69 | 2452 / 2642 | 51% | 2.25 | 358 / 705 |
esophagus | 79% | 25.06 | 1142 / 1445 | 50% | 12.81 | 92 / 183 |
uterus | 88% | 45.92 | 150 / 170 | 35% | 11.27 | 161 / 459 |
breast | 81% | 95.46 | 372 / 459 | 31% | 25.91 | 344 / 1118 |
lung | 77% | 28.51 | 443 / 578 | 29% | 16.90 | 335 / 1155 |
spleen | 98% | 43.12 | 237 / 241 | 0% | 0 | 0 / 0 |
bladder | 76% | 37.05 | 16 / 21 | 20% | 7.73 | 102 / 504 |
skin | 81% | 293.34 | 1473 / 1809 | 13% | 1.77 | 63 / 472 |
stomach | 82% | 23.69 | 295 / 359 | 10% | 0.80 | 30 / 286 |
pancreas | 83% | 24.14 | 272 / 328 | 10% | 2.55 | 17 / 178 |
thymus | 87% | 28.87 | 567 / 653 | 3% | 0.13 | 16 / 605 |
intestine | 76% | 22.14 | 733 / 966 | 12% | 1.89 | 65 / 527 |
kidney | 81% | 23.35 | 72 / 89 | 4% | 0.14 | 39 / 901 |
adrenal gland | 67% | 18.34 | 173 / 258 | 6% | 0.20 | 13 / 230 |
adipose | 63% | 20.75 | 760 / 1204 | 0% | 0 | 0 / 0 |
heart | 62% | 17.91 | 533 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 50% | 12.04 | 670 / 1335 | 0% | 0 | 0 / 0 |
liver | 46% | 9.55 | 105 / 226 | 2% | 0.06 | 9 / 406 |
peripheral blood | 35% | 8.63 | 329 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 20% | 11.88 | 9 / 45 |
muscle | 10% | 2.31 | 81 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.22 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045744 | Biological process | negative regulation of G protein-coupled receptor signaling pathway |
GO_0009566 | Biological process | fertilization |
GO_0070684 | Biological process | seminal clot liquefaction |
GO_0048730 | Biological process | epidermis morphogenesis |
GO_0006508 | Biological process | proteolysis |
GO_0045745 | Biological process | positive regulation of G protein-coupled receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0030141 | Cellular component | secretory granule |
GO_0005576 | Cellular component | extracellular region |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | KLK14 |
Protein name | Kallikrein M (Kallikrein related peptidase 14) Kallikrein-related peptidase 14 transcript variant 3 Kallikrein-related peptidase 14 transcript variant 2 Kallikrein-14 (hK14) (EC 3.4.21.-) (Kallikrein-like protein 6) (KLK-L6) |
Synonyms | KLKL6 KLK-L6 KLNM |
Description | FUNCTION: Serine-type endopeptidase with a dual trypsin-like and chymotrypsin-like substrate specificity. May activate/inactivate the proteinase-activated receptors F2R, F2RL1 and F2RL3 and other kallikreins including KLK1, KLK3, KLK5 and KLK11. May function in seminal clot liquefaction through direct cleavage of the semenogelin SEMG1 and SEMG2 and activation of KLK3. May function through desmoglein DSG1 cleavage in epidermal desquamation a process by which the most superficial corneocytes are shed from the skin surface. May be involved in several aspects of tumor progression including growth, invasion and angiogenesis. . |
Accessions | Q9P0G3 ENST00000391802.1 A0A1R3UHJ7 ENST00000156499.7 ENST00000650543.2 A0A3S6H8C4 A0A3Q8BCJ8 |